Greg Jones

1.1k total citations
22 papers, 473 citations indexed

About

Greg Jones is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Greg Jones has authored 22 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 18 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Greg Jones's work include Cancer Genomics and Diagnostics (19 papers), Lung Cancer Treatments and Mutations (16 papers) and Epigenetics and DNA Methylation (4 papers). Greg Jones is often cited by papers focused on Cancer Genomics and Diagnostics (19 papers), Lung Cancer Treatments and Mutations (16 papers) and Epigenetics and DNA Methylation (4 papers). Greg Jones collaborates with scholars based in United States, France and Canada. Greg Jones's co-authors include Roger Stupp, Monika E. Hegi, Joao V. Alessi, Mariano Severgnini, Marissa Lawrence, Tim Forshew, Christine Lydon, Biagio Ricciuti, Mizuki Nishino and Mark M. Awad and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Greg Jones

21 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Greg Jones United States	10	266	237	189	153	126	22	473
Mijke Bol Netherlands	7	118 0.4×	171 0.7×	137 0.7×	89 0.6×	71 0.6×	10	381
Aaron J. Schueneman United States	7	89 0.3×	109 0.5×	183 1.0×	158 1.0×	49 0.4×	8	377
Monica Milano Italy	10	176 0.7×	138 0.6×	311 1.6×	134 0.9×	20 0.2×	22	489
María Quindós Spain	9	180 0.7×	76 0.3×	166 0.9×	196 1.3×	64 0.5×	22	453
Angela Sciandivasci Italy	11	286 1.1×	191 0.8×	425 2.2×	100 0.7×	22 0.2×	23	593
Tomoyuki Aruga Japan	13	161 0.6×	132 0.6×	230 1.2×	71 0.5×	30 0.2×	59	403
Grazia Maria Vernaci Italy	11	250 0.9×	147 0.6×	408 2.2×	69 0.5×	24 0.2×	27	525
Nik Sol Netherlands	9	248 0.9×	77 0.3×	146 0.8×	258 1.7×	54 0.4×	21	411
K. Kian Ang United States	7	152 0.6×	107 0.5×	159 0.8×	171 1.1×	36 0.3×	7	406
Risa Oshitanai Japan	8	78 0.3×	238 1.0×	331 1.8×	46 0.3×	61 0.5×	15	431

Countries citing papers authored by Greg Jones

Since Specialization

Citations

This map shows the geographic impact of Greg Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Jones more than expected).

Fields of papers citing papers by Greg Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Jones. The network helps show where Greg Jones may publish in the future.

Co-authorship network of co-authors of Greg Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Jones. A scholar is included among the top collaborators of Greg Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Jones. Greg Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Baehner, Frederick L., James Chen, Carin R. Espenschied, et al.. (2024). Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages. Diagnostics. 14(9). 912–912. 1 indexed citations

2.

Mahmood, Kamran, Jeffrey Clarke, Steven Wolf, et al.. (2023). High Yield of Pleural Cell-Free DNA for Diagnosis of Oncogenic Mutations in Lung Adenocarcinoma. CHEST Journal. 164(1). 252–261. 9 indexed citations

3.

Breadner, Daniel, Mark Vincent, Rohann Correa, et al.. (2022). Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: A first-in-human pilot study. Lung Cancer. 165. 145–151. 9 indexed citations

4.

Yeung, Vincent, Grace W. K. Ho, Greg Jones, et al.. (2022). Osimertinib and Capmatinib Combination Therapy to Overcome MET Y1003N-Mediated Resistance in EGFR-Mutant NSCLC: A Case Report. JTO Clinical and Research Reports. 3(10). 100396–100396. 4 indexed citations

5.

Lafata, Kyle J., Michael N. Corradetti, Junheng Gao, et al.. (2021). Radiogenomic Analysis of Locally Advanced Lung Cancer Based on CT Imaging and Intratreatment Changes in Cell-Free DNA. Radiology Imaging Cancer. 3(4). e200157–e200157. 35 indexed citations

6.

Ricciuti, Biagio, Greg Jones, Mariano Severgnini, et al.. (2021). Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC). Journal for ImmunoTherapy of Cancer. 9(3). e001504–e001504. 108 indexed citations

7.

Remón, Jordi, Aurélie Swalduz, David Planchard, et al.. (2020). Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay. PLoS ONE. 15(6). e0234302–e0234302. 14 indexed citations

8.

Breadner, Daniel, Mark Vincent, Rohann Correa, et al.. (2020). Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: A first-in-human pilot study.. Journal of Clinical Oncology. 38(15_suppl). 3530–3530. 2 indexed citations

9.

Ricciuti, Biagio, Greg Jones, Anika E. Adeni, et al.. (2020). Early plasma circulating tumor DNA (ctDNA) changes to predict response to first-line pembrolizumab +/- chemotherapy in non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 38(15_suppl). 3518–3518. 2 indexed citations

10.

Corradetti, Michael N., Jordan A. Torok, Ace J. Hatch, et al.. (2019). Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer. Advances in Radiation Oncology. 4(4). 748–752. 12 indexed citations

11.

Xi, Liqiang, Constance M. Cultraro, Fengcai Wei, et al.. (2019). P1.01-27 Serial Circulating Tumor DNA (ctDNA) Analysis of Blood and Saliva Predicts Osimertinib Response and Resistance in EGFR-Mutant NSCLC. Journal of Thoracic Oncology. 14(10). S366–S366. 1 indexed citations

12.

Guibert, Nicolas, Greg Jones, John F. Beeler, et al.. (2019). Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer. Lung Cancer. 137. 1–6. 78 indexed citations

13.

Guibert, Nicolas, Greg Jones, John F. Beeler, et al.. (2019). Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.. Journal of Clinical Oncology. 37(8_suppl). 103–103. 10 indexed citations

14.

Hegi, Monika E., Thierry Gorlia, Roger Stupp, et al.. (2018). MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials. Clinical Cancer Research. 25(6). 1809–1816. 90 indexed citations

15.

Akbari, Khalid, et al.. (2018). The Effect of Bariatric Surgery on Patients with HIV Infection: a Literature Review. Obesity Surgery. 28(8). 2550–2559. 17 indexed citations

16.

Guibert, Nicolas, Greg Jones, John F. Beeler, et al.. (2018). Early prediction of outcomes to PD1 inhibitors in non-small cell lung cancer (NSCLC) using next generation sequencing (NGS) of plasma circulating tumor DNA (ctDNA).. Journal of Clinical Oncology. 36(15_suppl). 9078–9078. 2 indexed citations

17.

Bradbury, Penelope Ann, Keyue Ding, Peter Ellis, et al.. (2017). Evaluation of stored liquid biopsies for molecular profiling in patients with non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 35(15_suppl). 9024–9024. 1 indexed citations

18.

Corradetti, Michael N., Ace J. Hatch, Jordan A. Torok, et al.. (2017). Dynamic Changes in Cell-Free DNA During Chemoradiation for Non–small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). S114–S115.

19.

Sciuscio, Davide, Annie‐Claire Diserens, Danielle Martinet, et al.. (2010). Extent and Patterns of MGMT Promoter Methylation in Glioblastoma- and Respective Glioblastoma-Derived Spheres. Clinical Cancer Research. 17(2). 255–266. 68 indexed citations

20.

Aldape, Kenneth, Greg Jones, Monika E. Hegi, et al.. (2009). MGMT methylation testing in RTOG 0525: A phase III trial of newly diagnosed glioblastoma. Journal of Clinical Oncology. 27(15_suppl). 2051–2051. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact